Work

Health care resource utilization and costs in patients receiving long-acting injectable vs oral antipsychotics: A comparative analysis from the Disease Recovery Evaluation and Modification (DREaM) study

Year: 2022

Type: article

Abstract: Dr Basu reports consulting fees through Salutis Consulting LLC related to this work. Ms Benson, Dr Turkoz, Ms Patel, Dr Baker, and Dr Brown are employees of Janssen Scientific Affairs, LLC, and stockholders of Johnson & Johnson, Inc. This research was funded by Janssen Scientific Affairs, LLC. The sponsor was involved in the study design; collection, analysis, and interpretation of data; development and review of the manuscript; and decision to submit the manuscript for publication.

Source: Journal of Managed Care & Specialty Pharmacy

DOI: 10.18553/jmcp.2022.28.10.1086

Authors: Anirban Basu, Carmela Benson, Ibrahim Turkoz, Charmi Patel, Pamela Baker, Brianne Brown

Institutions: University of Washington, Janssen Scientific Affairs (United States)

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: Janssen Scientific Affairs